To investigate the impact of TRAIL, a widely used agent in cancer clinical studies (140, 141) on macrophage cytotoxic response against AML cells, macrophages were co-cultured with the acute myeloid leukemia (AML) cell line (U937) and macrophage-induced AML cell killing was determined. This evidence concerns the gene TNFSF10 and cancer.